Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Obesity | Research

Sex- and reproductive status-specific relationships between body composition and non-alcoholic fatty liver disease

Authors: Yu-tian Cao, Wen-hui Zhang, Yan Lou, Qian-hua Yan, Yu-juan Zhang, Fang Qi, Liu-lan Xiang, Tian-su Lv, Zhu-yuan Fang, Jiang-yi Yu, Xi-qiao Zhou

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

Sex and reproductive status differences exist in both non-alcoholic fatty liver disease (NAFLD) and body composition. Our purpose was to investigate the relationship between body composition and the severity of liver steatosis and fibrosis in NAFLD in different sex and reproductive status populations.

Methods

This cross-sectional study included 880 patients (355 men, 417 pre-menopausal women, 108 post-menopausal women). Liver steatosis and fibrosis and body composition data were measured using FibroScan and a bioelectrical impedance body composition analyzer (BIA), respectively, and the following parameters were obtained: liver stiffness measurement (LSM), controlled attenuation parameter (CAP), waist circumference (WC), body mass index (BMI), percent body fat (PBF), visceral fat area (VFA), appendicular skeletal muscle mass (ASM), appendicular skeletal muscle mass index (ASMI), fat mass (FM), fat free mass (FFM), and FFM to FM ratio (FFM/FM). Multiple ordinal logistic regression (MOLR) was used to analyze the independent correlation between body composition indicators and liver steatosis grade and fibrosis stage in different sex and menopausal status populations.

Results

Men had higher WC, ASM, ASMI, FFM, and FFM/FM than pre- or post-menopausal women, while pre-menopausal women had higher PBF, VFA, and FM than the other two groups (p < 0.001). Besides, men had greater CAP and LSM values (p < 0.001). For MOLR, after adjusting for confounding factors, WC (OR, 1.07; 95% CI, 1.02–1.12; P = 0.011) and FFM/FM (OR, 0.52; 95% CI, 0.31–0.89; P = 0.017) in men and visceral obesity (OR, 4.16; 95% CI, 1.09–15.90; P = 0.037) in post-menopausal women were independently associated with liver steatosis grade. WC and visceral obesity were independently associated with liver fibrosis stage in men (OR, 1.05; 95% CI, 1.01–1.09, P = 0.013; OR, 3.92; 95% CI, 1.97–7.81; P < 0.001, respectively).

Conclusions

Increased WC and low FFM/FM in men and visceral obesity in post-menopausal women were independent correlates of more severe liver steatosis. In addition, increased WC and visceral obesity were independent correlates of worse liver fibrosis in men. These data support the sex- and reproductive status-specific management of NAFLD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cotter TG, Rinella M. Nonalcoholic fatty Liver Disease 2020: the state of the Disease. Gastroenterology. 2020;158(7):1851–64.PubMed Cotter TG, Rinella M. Nonalcoholic fatty Liver Disease 2020: the state of the Disease. Gastroenterology. 2020;158(7):1851–64.PubMed
2.
go back to reference Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84.PubMed Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84.PubMed
3.
go back to reference Angulo P. Nonalcoholic fatty Liver Disease. N Engl J Med. 2002;346(16):1221–31.PubMed Angulo P. Nonalcoholic fatty Liver Disease. N Engl J Med. 2002;346(16):1221–31.PubMed
4.
go back to reference Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, et al. Sex differences in nonalcoholic fatty Liver Disease: state of the art and identification of Research Gaps. Hepatology. 2019;70(4):1457–69.PubMed Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, et al. Sex differences in nonalcoholic fatty Liver Disease: state of the art and identification of Research Gaps. Hepatology. 2019;70(4):1457–69.PubMed
5.
go back to reference DiStefano JK. NAFLD and NASH in Postmenopausal women: implications for diagnosis and treatment. Endocrinology. 2020;161(10):bqaa134.PubMedPubMedCentral DiStefano JK. NAFLD and NASH in Postmenopausal women: implications for diagnosis and treatment. Endocrinology. 2020;161(10):bqaa134.PubMedPubMedCentral
6.
go back to reference Karastergiou K, Smith SR, Greenberg AS, Fried SK. Sex differences in human adipose tissues - the biology of pear shape. Biol Sex Differ. 2012;3(1):13.PubMedPubMedCentral Karastergiou K, Smith SR, Greenberg AS, Fried SK. Sex differences in human adipose tissues - the biology of pear shape. Biol Sex Differ. 2012;3(1):13.PubMedPubMedCentral
7.
go back to reference Kim D, Chung GE, Kwak MS, Seo HB, Kang JH, Kim W, et al. Body Fat distribution and risk of Incident and regressed nonalcoholic fatty Liver Disease. Clin Gastroenterol Hepatol. 2016;14(1):132–8e4.PubMed Kim D, Chung GE, Kwak MS, Seo HB, Kang JH, Kim W, et al. Body Fat distribution and risk of Incident and regressed nonalcoholic fatty Liver Disease. Clin Gastroenterol Hepatol. 2016;14(1):132–8e4.PubMed
8.
go back to reference Koo BK, Kim D, Joo SK, Kim JH, Chang MS, Kim BG, et al. Sarcopenia is an Independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. J Hepatol. 2017;66(1):123–31.PubMed Koo BK, Kim D, Joo SK, Kim JH, Chang MS, Kim BG, et al. Sarcopenia is an Independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. J Hepatol. 2017;66(1):123–31.PubMed
9.
go back to reference Pan XY, Liu WY, Zhu PW, Li G, Tang LJ, Gao F, et al. Low skeletal muscle mass is associated with more severe histological features of non-alcoholic fatty Liver Disease in male. Hepatol Int. 2022;16(5):1085–93.PubMed Pan XY, Liu WY, Zhu PW, Li G, Tang LJ, Gao F, et al. Low skeletal muscle mass is associated with more severe histological features of non-alcoholic fatty Liver Disease in male. Hepatol Int. 2022;16(5):1085–93.PubMed
10.
go back to reference Ishibashi E, Eguchi Y, Eguchi T, Matsunobu A, Oza N, Nakashita S, et al. Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non-alcoholic fatty Liver Disease, but not in females. J Gastroenterol Hepatol. 2008;23(6):908–13.PubMed Ishibashi E, Eguchi Y, Eguchi T, Matsunobu A, Oza N, Nakashita S, et al. Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non-alcoholic fatty Liver Disease, but not in females. J Gastroenterol Hepatol. 2008;23(6):908–13.PubMed
11.
go back to reference Berger A, Shili S, Zuberbuhler F, Hiriart JB, Lannes A, Chermak F, et al. Liver stiffness measurement with FibroScan: use the right probe in the right conditions! Clin Transl Gastroenterol. 2019;10(4):e00023.PubMedPubMedCentral Berger A, Shili S, Zuberbuhler F, Hiriart JB, Lannes A, Chermak F, et al. Liver stiffness measurement with FibroScan: use the right probe in the right conditions! Clin Transl Gastroenterol. 2019;10(4):e00023.PubMedPubMedCentral
12.
go back to reference Castera L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology. 2010;51(3):828–35.PubMed Castera L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology. 2010;51(3):828–35.PubMed
13.
go back to reference Cao YT, Xiang LL, Qi F, Zhang YJ, Chen Y, Zhou XQ. Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty Liver Disease: a systematic review and meta-analysis. EClinicalMedicine. 2022;51:101547.PubMedPubMedCentral Cao YT, Xiang LL, Qi F, Zhang YJ, Chen Y, Zhou XQ. Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty Liver Disease: a systematic review and meta-analysis. EClinicalMedicine. 2022;51:101547.PubMedPubMedCentral
14.
go back to reference Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–07e2.PubMed Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–07e2.PubMed
15.
go back to reference Examination Committee of Criteria for. Obesity Disease’ in Japan, Japan Society for the Study of Obesity. New criteria for ‘obesity Disease’ in Japan. Circ J. 2002;66(11):987–92. Examination Committee of Criteria for. Obesity Disease’ in Japan, Japan Society for the Study of Obesity. New criteria for ‘obesity Disease’ in Japan. Circ J. 2002;66(11):987–92.
16.
go back to reference Wang M, Kartsonaki C, Guo Y, Lv J, Gan W, Chen ZM, et al. Factors related to age at natural menopause in China: results from the China Kadoorie Biobank. Menopause. 2021;28(10):1130–42.PubMedPubMedCentral Wang M, Kartsonaki C, Guo Y, Lv J, Gan W, Chen ZM, et al. Factors related to age at natural menopause in China: results from the China Kadoorie Biobank. Menopause. 2021;28(10):1130–42.PubMedPubMedCentral
17.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.PubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.PubMed
18.
go back to reference American Diabetes Association. 2. Classification and diagnosis of Diabetes: standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):15–S33. American Diabetes Association. 2. Classification and diagnosis of Diabetes: standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):15–S33.
19.
go back to reference Joint committee for guideline revision. 2016 Chinese guidelines for the management of dyslipidemia in adults. J Geriatr Cardiol. 2018;15(1):1–29.PubMedCentral Joint committee for guideline revision. 2016 Chinese guidelines for the management of dyslipidemia in adults. J Geriatr Cardiol. 2018;15(1):1–29.PubMedCentral
21.
go back to reference Lumish HS, O’Reilly M, Reilly MP. Sex differences in Genomic Drivers of Adipose Distribution and related Cardiometabolic disorders: opportunities for Precision Medicine. Arterioscler Thromb Vasc Biol. 2020;40(1):45–60.PubMed Lumish HS, O’Reilly M, Reilly MP. Sex differences in Genomic Drivers of Adipose Distribution and related Cardiometabolic disorders: opportunities for Precision Medicine. Arterioscler Thromb Vasc Biol. 2020;40(1):45–60.PubMed
22.
go back to reference Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond). 2008;32(6):949–58.PubMed Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond). 2008;32(6):949–58.PubMed
23.
go back to reference Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE, Magi R, et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature. 2015;518(7538):187–96.PubMedPubMedCentral Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE, Magi R, et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature. 2015;518(7538):187–96.PubMedPubMedCentral
24.
go back to reference Winkler TW, Justice AE, Graff M, Barata L, Feitosa MF, Chu S, et al. The influence of Age and Sex on Genetic associations with adult body size and shape: a large-scale genome-wide Interaction Study. PLoS Genet. 2015;11(10):e1005378.PubMedPubMedCentral Winkler TW, Justice AE, Graff M, Barata L, Feitosa MF, Chu S, et al. The influence of Age and Sex on Genetic associations with adult body size and shape: a large-scale genome-wide Interaction Study. PLoS Genet. 2015;11(10):e1005378.PubMedPubMedCentral
25.
go back to reference Randall JC, Winkler TW, Kutalik Z, Berndt SI, Jackson AU, Monda KL, et al. Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet. 2013;9(6):e1003500.PubMedPubMedCentral Randall JC, Winkler TW, Kutalik Z, Berndt SI, Jackson AU, Monda KL, et al. Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet. 2013;9(6):e1003500.PubMedPubMedCentral
26.
go back to reference Long MT, Pedley A, Massaro JM, Hoffmann U, Ma J, Loomba R, et al. A simple clinical model predicts incident hepatic steatosis in a community-based cohort: the Framingham Heart Study. Liver Int. 2018;38(8):1495–503.PubMedPubMedCentral Long MT, Pedley A, Massaro JM, Hoffmann U, Ma J, Loomba R, et al. A simple clinical model predicts incident hepatic steatosis in a community-based cohort: the Framingham Heart Study. Liver Int. 2018;38(8):1495–503.PubMedPubMedCentral
27.
go back to reference Vistisen B, Hellgren LI, Vadset T, Scheede-Bergdahl C, Helge JW, Dela F, et al. Effect of gender on lipid-induced insulin resistance in obese subjects. Eur J Endocrinol. 2008;158(1):61–8.PubMed Vistisen B, Hellgren LI, Vadset T, Scheede-Bergdahl C, Helge JW, Dela F, et al. Effect of gender on lipid-induced insulin resistance in obese subjects. Eur J Endocrinol. 2008;158(1):61–8.PubMed
28.
go back to reference Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F, et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab. 1996;81(9):3424–7.PubMed Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F, et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab. 1996;81(9):3424–7.PubMed
29.
go back to reference Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for Independent roles of age and sex. Diabetologia. 2003;46(4):459–69.PubMed Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for Independent roles of age and sex. Diabetologia. 2003;46(4):459–69.PubMed
30.
go back to reference Handgraaf S, Riant E, Fabre A, Waget A, Burcelin R, Liere P, et al. Prevention of obesity and insulin resistance by estrogens requires ERalpha activation function-2 (ERalphaAF-2), whereas ERalphaAF-1 is dispensable. Diabetes. 2013;62(12):4098–108.PubMedPubMedCentral Handgraaf S, Riant E, Fabre A, Waget A, Burcelin R, Liere P, et al. Prevention of obesity and insulin resistance by estrogens requires ERalpha activation function-2 (ERalphaAF-2), whereas ERalphaAF-1 is dispensable. Diabetes. 2013;62(12):4098–108.PubMedPubMedCentral
31.
go back to reference Zhu L, Brown WC, Cai Q, Krust A, Chambon P, McGuinness OP, et al. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance. Diabetes. 2013;62(2):424–34.PubMedPubMedCentral Zhu L, Brown WC, Cai Q, Krust A, Chambon P, McGuinness OP, et al. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance. Diabetes. 2013;62(2):424–34.PubMedPubMedCentral
32.
go back to reference Yang M, Liu Q, Huang T, Tan W, Qu L, Chen T, et al. Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development. Theranostics. 2020;10(24):10874–91.PubMedPubMedCentral Yang M, Liu Q, Huang T, Tan W, Qu L, Chen T, et al. Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development. Theranostics. 2020;10(24):10874–91.PubMedPubMedCentral
33.
go back to reference Hallajzadeh J, Khoramdad M, Izadi N, Karamzad N, Almasi-Hashiani A, Ayubi E, et al. Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies. Menopause. 2018;25(10):1155–64.PubMed Hallajzadeh J, Khoramdad M, Izadi N, Karamzad N, Almasi-Hashiani A, Ayubi E, et al. Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies. Menopause. 2018;25(10):1155–64.PubMed
34.
go back to reference Zhang B, Zhang CG, Ji LH, Zhao G, Wu ZY. Estrogen receptor beta selective agonist ameliorates liver Cirrhosis in rats by inhibiting the activation and proliferation of hepatic stellate cells. J Gastroenterol Hepatol. 2018;33(3):747–55.PubMed Zhang B, Zhang CG, Ji LH, Zhao G, Wu ZY. Estrogen receptor beta selective agonist ameliorates liver Cirrhosis in rats by inhibiting the activation and proliferation of hepatic stellate cells. J Gastroenterol Hepatol. 2018;33(3):747–55.PubMed
35.
go back to reference Shimizu I, Mizobuchi Y, Yasuda M, Shiba M, Ma YR, Horie T, et al. Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and in vitro. Gut. 1999;44(1):127–36.PubMedPubMedCentral Shimizu I, Mizobuchi Y, Yasuda M, Shiba M, Ma YR, Horie T, et al. Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and in vitro. Gut. 1999;44(1):127–36.PubMedPubMedCentral
36.
go back to reference Yang JD, Abdelmalek MF, Pang H, Guy CD, Smith AD, Diehl AM, et al. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology. 2014;59(4):1406–14.PubMed Yang JD, Abdelmalek MF, Pang H, Guy CD, Smith AD, Diehl AM, et al. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology. 2014;59(4):1406–14.PubMed
37.
go back to reference Marcos R, Correia-Gomes C, Miranda H, Carneiro F. Liver gender dimorphism–insights from quantitative morphology. Histol Histopathol. 2015;30(12):1431–7.PubMed Marcos R, Correia-Gomes C, Miranda H, Carneiro F. Liver gender dimorphism–insights from quantitative morphology. Histol Histopathol. 2015;30(12):1431–7.PubMed
38.
go back to reference Schwenger KJP, Kiu A, AlAli M, Alhanaee A, Fischer SE, Allard JP. Comparison of bioelectrical impedance analysis, mass index, and waist circumference in assessing risk for non-alcoholic steatohepatitis. Nutrition. 2022;93:111491.PubMed Schwenger KJP, Kiu A, AlAli M, Alhanaee A, Fischer SE, Allard JP. Comparison of bioelectrical impedance analysis, mass index, and waist circumference in assessing risk for non-alcoholic steatohepatitis. Nutrition. 2022;93:111491.PubMed
39.
go back to reference McLaughlin T, Lamendola C, Liu A, Abbasi F. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab. 2011;96(11):E1756–60.PubMedPubMedCentral McLaughlin T, Lamendola C, Liu A, Abbasi F. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab. 2011;96(11):E1756–60.PubMedPubMedCentral
40.
go back to reference Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908–22.PubMedPubMedCentral Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908–22.PubMedPubMedCentral
41.
go back to reference Peng TC, Wu LW, Chen WL, Liaw FY, Chang YW, Kao TW. Nonalcoholic fatty Liver Disease and sarcopenia in a western population (NHANES III): the importance of Sarcopenia definition. Clin Nutr. 2019;38(1):422–28.PubMed Peng TC, Wu LW, Chen WL, Liaw FY, Chang YW, Kao TW. Nonalcoholic fatty Liver Disease and sarcopenia in a western population (NHANES III): the importance of Sarcopenia definition. Clin Nutr. 2019;38(1):422–28.PubMed
42.
go back to reference Tomlinson DJ, Erskine RM, Morse CI, Winwood K, Onambele-Pearson G. The impact of obesity on skeletal muscle strength and structure through adolescence to old age. Biogerontology. 2016;17(3):467–83.PubMed Tomlinson DJ, Erskine RM, Morse CI, Winwood K, Onambele-Pearson G. The impact of obesity on skeletal muscle strength and structure through adolescence to old age. Biogerontology. 2016;17(3):467–83.PubMed
43.
go back to reference Baker JF, Harris T, Rapoport A, Ziolkowski SL, Leonard MB, Long J, et al. Validation of a description of sarcopenic obesity defined as excess adiposity and low lean mass relative to adiposity. J Cachexia Sarcopenia Muscle. 2020;11(6):1580–89.PubMedPubMedCentral Baker JF, Harris T, Rapoport A, Ziolkowski SL, Leonard MB, Long J, et al. Validation of a description of sarcopenic obesity defined as excess adiposity and low lean mass relative to adiposity. J Cachexia Sarcopenia Muscle. 2020;11(6):1580–89.PubMedPubMedCentral
44.
go back to reference Kurinami N, Sugiyama S, Morita A, Yoshida A, Hieshima K, Miyamoto F, et al. Ratio of muscle mass to fat mass assessed by bioelectrical impedance analysis is significantly correlated with liver fat accumulation in patients with type 2 Diabetes Mellitus. Diabetes Res Clin Pract. 2018;139:122–30.PubMed Kurinami N, Sugiyama S, Morita A, Yoshida A, Hieshima K, Miyamoto F, et al. Ratio of muscle mass to fat mass assessed by bioelectrical impedance analysis is significantly correlated with liver fat accumulation in patients with type 2 Diabetes Mellitus. Diabetes Res Clin Pract. 2018;139:122–30.PubMed
45.
go back to reference Seo YG, Song HJ, Song YR. Fat-to-muscle ratio as a predictor of insulin resistance and metabolic syndrome in Korean adults. J Cachexia Sarcopenia Muscle. 2020;11(3):710–25.PubMedPubMedCentral Seo YG, Song HJ, Song YR. Fat-to-muscle ratio as a predictor of insulin resistance and metabolic syndrome in Korean adults. J Cachexia Sarcopenia Muscle. 2020;11(3):710–25.PubMedPubMedCentral
46.
go back to reference Kim JA, Choi KM. Sarcopenia and fatty Liver Disease. Hepatol Int. 2019;13(6):674–87.PubMed Kim JA, Choi KM. Sarcopenia and fatty Liver Disease. Hepatol Int. 2019;13(6):674–87.PubMed
47.
go back to reference Dai H, Xiang J, Hou Y, Xuan L, Wang T, Li M, et al. Fat mass to fat-free mass ratio and the risk of non-alcoholic fatty Liver Disease and fibrosis in non-obese and obese individuals. Nutr Metab (Lond). 2021;18(1):21.PubMed Dai H, Xiang J, Hou Y, Xuan L, Wang T, Li M, et al. Fat mass to fat-free mass ratio and the risk of non-alcoholic fatty Liver Disease and fibrosis in non-obese and obese individuals. Nutr Metab (Lond). 2021;18(1):21.PubMed
Metadata
Title
Sex- and reproductive status-specific relationships between body composition and non-alcoholic fatty liver disease
Authors
Yu-tian Cao
Wen-hui Zhang
Yan Lou
Qian-hua Yan
Yu-juan Zhang
Fang Qi
Liu-lan Xiang
Tian-su Lv
Zhu-yuan Fang
Jiang-yi Yu
Xi-qiao Zhou
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02997-9

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.